CY1119600T1 - Διαδικασια για την παραγωγη κλασματων γαλακτος πλουσιων σε εκκριτικες ανοσοσφαιρινες - Google Patents
Διαδικασια για την παραγωγη κλασματων γαλακτος πλουσιων σε εκκριτικες ανοσοσφαιρινεςInfo
- Publication number
- CY1119600T1 CY1119600T1 CY20171101171T CY171101171T CY1119600T1 CY 1119600 T1 CY1119600 T1 CY 1119600T1 CY 20171101171 T CY20171101171 T CY 20171101171T CY 171101171 T CY171101171 T CY 171101171T CY 1119600 T1 CY1119600 T1 CY 1119600T1
- Authority
- CY
- Cyprus
- Prior art keywords
- iga
- treatment
- present
- production
- rich
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
- A23J3/10—Casein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Η παρούσα εφεύρεση αφορά σε μια διαδικασία για την παραγωγή συνθέσεων οι οποίες είναι πλούσιες σε εκκριτική IgA (S-IgA) με κλασματοποίηση γάλακτος που περιέχει S-IgA. Τέτοιες συνθέσεις μπορούν να χρησιμοποιηθούν ειδικότερα για τη θεραπεία και/ή την πρόληψη μολύνσεων και/ή φλεγμονής των επιφανειών του βλεννογόνου, π.χ. της γαστρεντερικής οδού, της ουρογεννητικής οδού, της αναπνευστικής οδού, της ρινικής κοιλότητας ή της στοματικής κοιλότητας, για τη θεραπεία και/ή την πρόληψη της παχυσαρκίας και των συναφών ασθενειών ή για τη θεραπεία και/ή την πρόληψη των τροφικών αλλεργιών σε άτομα που έχουν ανάγκη τέτοιας θεραπείας. Εν συντομία, η παρούσα εφεύρεση παρέχει μία διαδικασία για την παραγωγή κλασμάτων γάλακτος πλούσιων σε εκκριτική ανοσοσφαιρίνη Α, χρησιμοποιώντας ένα ή περισσότερα στάδια διήθησης σε μικροπορώδη μεμβράνη. Ένα προτιμώμενο πρωτόκολλο της παρούσας διαδικασίας περιλαμβάνει την απολίπανση, τη μικροδιήθηση και την υπερδιήθηση-συμπύκνωση μέσω ενός αριθμού κύκλων διαδιήθησης. Η διαδικασία της εφεύρεσης εκτός από τις απροσδόκητα υψηλές αποδόσεις που μπορούν να επιτευχθούν, προσφέρει πλεονεκτήματα τα οποία παρουσιάζουν ιδιαίτερο ενδιαφέρον από την άποψη της κλιμακοθετησιμότητας, της εφαρμογής σε υφιστάμενα εργοστάσια γαλακτοκομικών και της δυνατότητας ελέγχου των παραμέτρων της διαδικασίας που επηρεάζουν την ποιότητα και τη σταθερότητα της S-IgA.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5324408P | 2008-05-15 | 2008-05-15 | |
EP08156217 | 2008-05-15 | ||
EP09746801.1A EP2280999B1 (en) | 2008-05-15 | 2009-05-11 | Process for producing milk fractions rich in secretory immunoglobulins |
PCT/NL2009/050248 WO2009139624A1 (en) | 2008-05-15 | 2009-05-11 | Process for producing milk fractions rich in secretory immunoglobulins |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1119600T1 true CY1119600T1 (el) | 2018-04-04 |
Family
ID=39811649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20171101171T CY1119600T1 (el) | 2008-05-15 | 2017-11-08 | Διαδικασια για την παραγωγη κλασματων γαλακτος πλουσιων σε εκκριτικες ανοσοσφαιρινες |
Country Status (15)
Country | Link |
---|---|
US (1) | US8669353B2 (el) |
EP (1) | EP2280999B1 (el) |
JP (1) | JP5762951B2 (el) |
KR (1) | KR101645957B1 (el) |
CN (1) | CN102124027B (el) |
AU (1) | AU2009247031B2 (el) |
BR (1) | BRPI0911994A2 (el) |
CA (1) | CA2724444C (el) |
CY (1) | CY1119600T1 (el) |
DK (1) | DK2280999T3 (el) |
ES (1) | ES2644983T3 (el) |
NZ (1) | NZ589297A (el) |
PL (1) | PL2280999T3 (el) |
RU (1) | RU2010151414A (el) |
WO (1) | WO2009139624A1 (el) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8709413B2 (en) * | 2006-12-13 | 2014-04-29 | Michael R. Simon | Treatment of celiac disease with IgA |
EP2725035A1 (en) | 2007-10-02 | 2014-04-30 | Avaxia Biologics, Inc. | Antibody therapy for use in the digestive tract |
EP2138186A1 (en) | 2008-06-24 | 2009-12-30 | Nestec S.A. | Probiotics, secretory IgA and inflammation |
IT1405998B1 (it) * | 2010-12-09 | 2014-02-06 | Bionest Ltd | Gel polifunzionale contro la secchezza vaginale ad effetto diretto e ritardato |
DK2739157T3 (en) | 2011-08-03 | 2018-01-08 | Prolacta Bioscience Inc | Microfiltration of human milk to reduce bacterial contamination |
MY182178A (en) * | 2011-09-01 | 2021-01-18 | Chugai Pharmaceutical Co Ltd | Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration |
SG11201402928UA (en) * | 2011-12-21 | 2014-07-30 | Colgate Palmolive Co | Heatiness and salivary secretory immunoglobulin |
WO2013132052A1 (en) | 2012-03-09 | 2013-09-12 | Csl Behring Ag | Compositions comprising secretory - like immunoglobulins |
EP2636681A1 (en) | 2012-03-09 | 2013-09-11 | CSL Behring AG | Process for enriching IgA |
EP2636684A1 (en) | 2012-03-09 | 2013-09-11 | CSL Behring AG | Prevention of infection |
CA2869023A1 (en) | 2012-04-05 | 2013-10-10 | Gottfried Himmler | Secretory immunoglobulin complex |
WO2013174971A1 (en) | 2012-05-25 | 2013-11-28 | Gottfried Himmler | Secretory immunoglobulin deficiency treatment and prophlaxis |
US9458230B2 (en) | 2013-01-04 | 2016-10-04 | Wisconsin Alumni Research Foundation | Secretory IGA compositions, methods of making and methods of use thereof |
EP2762490A1 (de) * | 2013-01-31 | 2014-08-06 | DMK Deutsches Milchkontor GmbH | Verfahren zur Gewinnung von Immunoglobulinen aus Kolostralmilch |
US9765151B2 (en) * | 2013-03-11 | 2017-09-19 | Cured Inc. | Method for producing monoclonal IgA antibody |
US9468674B2 (en) | 2013-09-24 | 2016-10-18 | Wisconsin Alumni Research Foundation | Methods of use of secretory IgA |
KR20210013597A (ko) * | 2018-05-17 | 2021-02-04 | 체에스엘 베링 아게 | 단백질 추출 방법 및 시스템 |
WO2020260502A1 (en) * | 2019-06-28 | 2020-12-30 | Societe Des Produits Nestle S.A. | COMPOSITIONS COMPRISING SECRETORY IgA AND PROBIOTICS |
EP4393321A2 (en) | 2019-07-23 | 2024-07-03 | FrieslandCampina Nederland B.V. | Nutritional composition comprising milk fat and immunoglobulin |
JP2023502412A (ja) * | 2019-11-20 | 2023-01-24 | ツェー・エス・エル・ベーリング・アクチエンゲゼルシャフト | 沈殿物からタンパク質を抽出する方法および不純物を沈殿させる方法 |
EP4294214A1 (en) * | 2021-02-16 | 2023-12-27 | FrieslandCampina Nederland B.V. | Milk with a high immunoglobulin content |
WO2023159093A1 (en) * | 2022-02-16 | 2023-08-24 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin |
CH719882A2 (de) * | 2022-07-11 | 2024-01-15 | Babylat Gmbh | Vorrichtungen und verfahren zur proteinanreicherung von muttermilch |
CN115808400A (zh) * | 2023-01-18 | 2023-03-17 | 黑龙江飞鹤乳业有限公司 | 分泌型免疫球蛋白a的检测方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH627079A5 (en) * | 1977-04-15 | 1981-12-31 | Nestle Sa | Process for preparing a protein concentrate containing immunological factors of milk origin |
EP0047597A1 (en) * | 1980-09-04 | 1982-03-17 | Wirsbo Bruks Aktiebolag | Improvements in and relating to the testing of pipes |
DE3432718C1 (de) | 1984-09-06 | 1986-05-22 | Biotest Pharma GmbH, 6000 Frankfurt | Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen |
JP3145696B2 (ja) * | 1990-10-05 | 2001-03-12 | 日本ケミカルリサーチ株式会社 | 分泌型免疫グロブリンa製剤の製造法 |
US5258177A (en) * | 1991-12-10 | 1993-11-02 | Alpha Therapeutic Corporation | IgA preparation and process of making the same |
WO1994013148A1 (en) | 1992-12-11 | 1994-06-23 | Immunotec Research Corporation Ltd. | Process for producing an undernatured whey protein concentrate |
HUT77043A (hu) | 1994-09-16 | 1998-03-02 | New Zealand Dairy Board | Kazein és savófehérjék fizikai elválasztása |
AUPP806999A0 (en) | 1999-01-08 | 1999-02-04 | Csl Limited | Process for purifying immunoglobulins |
AU5719600A (en) | 1999-07-07 | 2001-01-30 | New Zealand Co-Operative Dairy Company Limited | Method of obtaining protein isolates and concentrates from colostrum |
US6974573B2 (en) * | 1999-11-01 | 2005-12-13 | Mucovax Holdings, B.V. | Antibody production in farm animals |
US6875459B2 (en) | 2001-09-10 | 2005-04-05 | Henry B. Kopf | Method and apparatus for separation of milk, colostrum, and whey |
EP1601788A4 (en) * | 2003-02-24 | 2006-11-15 | Gtc Biotherapeutics Inc | TANGENTIAL FILTRATION METHODS AND APPARATUS THEREFOR |
US20060051347A1 (en) * | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
KR101496432B1 (ko) * | 2005-05-10 | 2015-02-27 | 머레이 걸번 코-어퍼러티브 컴퍼니 리미티드 | 면역글로불린 분획 및 이것의 제조 방법 |
-
2009
- 2009-05-11 RU RU2010151414/10A patent/RU2010151414A/ru not_active Application Discontinuation
- 2009-05-11 CN CN200980125340.4A patent/CN102124027B/zh not_active Expired - Fee Related
- 2009-05-11 KR KR1020107027834A patent/KR101645957B1/ko active IP Right Grant
- 2009-05-11 DK DK09746801.1T patent/DK2280999T3/da active
- 2009-05-11 EP EP09746801.1A patent/EP2280999B1/en not_active Not-in-force
- 2009-05-11 JP JP2011509426A patent/JP5762951B2/ja not_active Expired - Fee Related
- 2009-05-11 US US12/992,701 patent/US8669353B2/en not_active Expired - Fee Related
- 2009-05-11 BR BRPI0911994A patent/BRPI0911994A2/pt not_active Application Discontinuation
- 2009-05-11 ES ES09746801.1T patent/ES2644983T3/es active Active
- 2009-05-11 AU AU2009247031A patent/AU2009247031B2/en not_active Ceased
- 2009-05-11 WO PCT/NL2009/050248 patent/WO2009139624A1/en active Application Filing
- 2009-05-11 PL PL09746801T patent/PL2280999T3/pl unknown
- 2009-05-11 NZ NZ589297A patent/NZ589297A/en not_active IP Right Cessation
- 2009-05-11 CA CA2724444A patent/CA2724444C/en not_active Expired - Fee Related
-
2017
- 2017-11-08 CY CY20171101171T patent/CY1119600T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN102124027A (zh) | 2011-07-13 |
AU2009247031B2 (en) | 2014-05-29 |
CN102124027B (zh) | 2015-01-21 |
RU2010151414A (ru) | 2012-06-20 |
PL2280999T3 (pl) | 2018-02-28 |
KR20110036001A (ko) | 2011-04-06 |
CA2724444A1 (en) | 2009-11-19 |
BRPI0911994A2 (pt) | 2015-10-20 |
US20110130545A1 (en) | 2011-06-02 |
JP5762951B2 (ja) | 2015-08-12 |
JP2011523410A (ja) | 2011-08-11 |
EP2280999A1 (en) | 2011-02-09 |
CA2724444C (en) | 2019-11-26 |
ES2644983T3 (es) | 2017-12-01 |
AU2009247031A1 (en) | 2009-11-19 |
DK2280999T3 (da) | 2017-11-13 |
WO2009139624A1 (en) | 2009-11-19 |
EP2280999B1 (en) | 2017-09-06 |
NZ589297A (en) | 2011-12-22 |
KR101645957B1 (ko) | 2016-08-05 |
US8669353B2 (en) | 2014-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119600T1 (el) | Διαδικασια για την παραγωγη κλασματων γαλακτος πλουσιων σε εκκριτικες ανοσοσφαιρινες | |
CY1123152T1 (el) | Τροποποιημενες πρωτεϊνες rsv f και μεθοδοι χρησης τους | |
CY1110812T1 (el) | Παραγωγα διφαινυλοξυοξικου οξεος για τη θεραπεια αναπνευστικων διαταραχων | |
WO2010021874A3 (en) | Engineered anti-il-13 antibodies, compositions, methods and uses | |
CY1120033T1 (el) | Αντισωματα που προσδενουν il-4 και/ή il-13 και οι χρησεις τους | |
CY1116057T1 (el) | Παραγωγα κιναζολιν-4(3η)-ονης που χρησιμοποιουνται ως αναστολεις κινασης ρι3 | |
CY1116699T1 (el) | Παραγωγα αλφα-αμινοαμιδιου τα οποια ειναι χρησιμα στην αγωγη γνωστικων διαταραχων | |
SE0301010D0 (sv) | Novel compounds | |
CY1116264T1 (el) | Αντισωματα κατα ανθρωπινης αγγειοποιητινης 2 | |
DK1757276T3 (da) | Fremgangsmåde til fremstilling af nano- og mikrokapsler af edderkoppesilkeprotein | |
CY1116455T1 (el) | Υποκατεστημενα 4-αρυλο-1,4-διυδρο-1,6-ναφθυριδιν αμιδια και η χρηση τους | |
NO345046B1 (no) | Oral doseringsform | |
DE60211045D1 (de) | Verfahren zur Herstellung von geträgerten Zeolithmembranen durch temperaturgesteuerte Kristallisation | |
NO20082167L (no) | Anti-Myostatin-antistoffer | |
EA201270062A1 (ru) | Вакцина | |
DK2229949T3 (da) | Anvendelse af mælkesyrebakterier til nedsættelse af tandkødsblødning og reduktion af mundbetændelse | |
MXPA05009304A (es) | Derivados de indol utiles para el tratamiento de enfermedades. | |
EA201070414A1 (ru) | Способ получения не содержащего лактозу молока | |
WO2007068894A3 (en) | Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease | |
NO20063193L (no) | Fusjonerte pyrrolokarbazoler og fremgangsmater for fremstilling derav | |
EA200601462A1 (ru) | Соединения для лечения заболеваний | |
MX2011012622A (es) | Proteina de enlace de il-13. | |
GR20120100041A (el) | Απλες, αρωματισμενες ή διατροφικα ενισχυμενες σκονες απο γαλα γαϊδουρας και ολοκληρωμενη μεθοδος παραγωγης τους | |
WO2009137714A3 (en) | Forms of lapatinib ditosylate and processes for preparation thereof | |
NO20081617L (no) | Metoder for fremstilling av Glutaminsyrederivater |